Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

P2Y13 Inhibitors

The P2Y13 receptor is a member of the P2Y receptor family, which are G protein-coupled receptors responsive to extracellular nucleotides. They play a vital role in numerous physiological processes by mediating cellular responses to nucleotides like adenosine diphosphate (ADP). P2Y13, in particular, has been noted for its high affinity for ADP and has been studied in the context of its involvement in intracellular signaling cascades. The expression of P2Y13 can be influenced by a variety of factors, including the availability of its ligands and the dynamic regulation of its gene expression in response to cellular signals. Given this complexity, the expression levels of P2Y13 are tightly controlled, and any deviation from the norm could potentially affect the physiological functions it mediates. In the pursuit of understanding how to fine-tune the expression of P2Y13, various chemical compounds have been identified that could potentially serve as inhibitors. These inhibitors may function through several different mechanisms, such as directly blocking the receptor's active site, interfering with its ability to bind to ADP, or hindering the intracellular pathways that lead to its expression. For instance, compounds that exhibit antagonist properties toward other P2Y receptors might extend their inhibitory effects to P2Y13 by virtue of shared signaling pathways or through competition for common ligands. Additionally, some chemicals may inhibit kinases or other enzymes that are upstream modulators of P2Y13 expression, thus leading to a reduction in the receptor's presence on the cell surface. The interaction between these chemicals and P2Y13 is not straightforward, and it underscores the intricate nature of intracellular signaling and gene expression regulation. Understanding these interactions is crucial for mapping out the biochemical landscape in which P2Y13 operates, as well as for elucidating the diverse molecular mechanisms that govern its expression.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MRS 2211

sc-204101
sc-204101A
10 mg
50 mg
$118.00
$463.00
2
(0)

MRS 2211 is a selective P2Y13 receptor agonist that showcases unique molecular interactions, particularly through its ability to stabilize receptor conformations. This compound engages in specific hydrogen bonding and hydrophobic interactions, enhancing its affinity for the receptor. Its kinetic profile indicates a rapid onset of action, influencing intracellular signaling pathways. The compound's structural features promote distinct allosteric modulation, providing insights into receptor dynamics and purinergic signaling mechanisms.

MRS 2179 ammonium salt

101204-49-3sc-253058
5 mg
$313.00
1
(0)

By selectively antagonizing P2Y1 receptors, MRS 2179 may lead to a decrease in P2Y13 receptor expression through altered nucleotide signaling.

Clopidogrel

113665-84-2sc-507403
1 g
$122.00
1
(0)

The active metabolites of Clopidogrel could decrease P2Y13 receptor expression by inhibiting P2Y12 receptors and thus reducing ADP-mediated responses that can upregulate P2Y13.

Prasugrel

150322-43-3sc-391536
100 mg
$79.00
(0)

Prasugrel, through its antiplatelet action, could reduce P2Y13 receptor expression by lowering the availability of ADP, a known P2Y13 agonist.

Ticagrelor

274693-27-5sc-472972
sc-472972A
sc-472972B
sc-472972C
10 mg
25 mg
50 mg
100 mg
$104.00
$228.00
$270.00
$302.00
(0)

Ticagrelor inhibits P2Y12 receptors and could lead to a decreased expression of P2Y13 receptors by diminishing the ADP signaling that often upregulates P2Y13.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY 294002 inhibits PI3K, an upstream regulator of many signal transduction pathways; this inhibition could lead to decreased expression of P2Y13 receptors by altering transcriptional activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor that could decrease P2Y13 receptor expression by blocking the JNK signaling pathway, which is involved in the control of gene expression.